// Professor Weldon - Medicinal Chemistry Content
// Focus: BPH, ED, UI, Osteoporosis, and Gonadal Hormones Med Chem

import type { ProfessorContent } from './professorTypes';
import { weldonFlashcards } from './weldonFlashcards';
import { weldonQuiz } from './weldonQuiz';
import { weldonDrugCards } from './weldonDrugCards';

export const weldonContent: ProfessorContent = {
  id: 'weldon',
  name: 'Weldon',
  fullName: 'Professor Weldon',
  specialty: 'Medicinal Chemistry',
  icon: '⚗️',
  slideFiles: [
    'Weldon-MedChem Only-BPH, ED, and UI.pptx',
    'Weldon-MedChem-Osteoporosis_v2.pptx',
    'Weldon-MedChem-Gonadal Hormones.pptx'
  ],
  overview: {
    summary: 'Professor Weldon covers medicinal chemistry with emphasis on chemical structures, structure-activity relationships (SAR), drug design principles, metabolism, and what distinguishes drugs within the same class. Focus on understanding WHY structural modifications produce different pharmacological effects.',
    topics: [
      'BPH Medicinal Chemistry (Alpha-1 Antagonists, 5-Alpha-Reductase Inhibitors)',
      'Erectile Dysfunction Drug Structures (PDE5 Inhibitors, PGE1)',
      'Urinary Incontinence Med Chem (Antimuscarinics, Beta-3 Agonists, ADH Analogues)',
      'Osteoporosis Drug Chemistry (Bisphosphonates, PTH Analogues, Monoclonal Antibodies)',
      'Sex Hormone Classification (Estrogens, Progestins, Androgens)',
      'Estrogen Biosynthesis and Aromatase',
      'Estrogen Metabolism and Interconversion',
      'Synthetic Estrogen Development (Ethinyl Estradiol, Conjugated Estrogens)',
      'Estrogen SAR and Nonsteroidal Estrogens',
      'Estrogen Antagonists (Triphenylethylenes, SERMs, Aromatase Inhibitors)',
      'Progestin Chemistry (Pregnanes vs 19-Norandrostanes)',
      'Oral Contraceptive Progestin Comparison',
      'Androgen Chemistry and Anabolic Steroids'
    ],
    learningObjectives: [
      'Recognize quinazoline structure and "-azosin" suffix of alpha-1 antagonists',
      'Differentiate finasteride (type 2 selective) vs dutasteride (type 1+2 inhibitor) selectivity',
      'Understand that both 5-ARIs are steroidal in nature',
      'Identify pyrazolopyrimidinone class of PDE5 inhibitors',
      'Explain sulfonamide addition for water solubility in PDE5 inhibitors',
      'Understand guanine-based structure of PDE5 inhibitors (mimic GMP)',
      'Explain sildenafil\'s poor PDE5/PDE6 selectivity causing blue vision',
      'Define selectivity (one drug, multiple targets) vs potency (multiple drugs, one target)',
      'Recognize anticholinergics structurally resemble acetylcholine',
      'Identify beta-3 agonists structurally resemble epinephrine',
      'Understand bisphosphonates mimic IPP with P-C-P (vs P-O-P) for stability',
      'Recognize nitrogen-containing side chain increases BPP potency and toxicity (BRONJ)',
      'Differentiate PTH analogues as anabolic (not antiresorptive) agents',
      'Classify sex hormones: Estrogens (C18, aromatic A ring), Progestins (C21, 3-keto-4,5-ene), Androgens (C19)',
      'Know 3 classic estrogens: estrone, 17β-estradiol (most potent), estriol',
      'Understand aromatase (CYP19) converts androgens to estrogens',
      'Explain estradiol metabolism via hydroxylation and COMT',
      'Know estradiol ↔ estrone interconversion',
      'Understand 17α-ethinyl substitution blocks metabolism for oral activity',
      'Recognize mestranol as 3-O-methyl prodrug of ethinyl estradiol',
      'Know estradiol esters (valerate, cypionate) for long-acting IM therapy',
      'Identify conjugated estrogens from pregnant mare urine (Premarin)',
      'Apply estrogen SAR: removal of C3 or C17 oxygen diminishes activity',
      'Know stilbene derivatives (DES) are nonsteroidal estrogens',
      'Classify estrogen antagonists: impeded, triphenylethylenes, aromatase inhibitors',
      'Understand triphenylethylene mechanism (persistent binding, prevent translocation)',
      'Know clomiphene has E (antiestrogenic) and Z (estrogenic) isomers',
      'Identify tamoxifen metabolism: CYP3A4 (demethylation), CYP2D6 (4-hydroxy = active)',
      'Understand aromatase inhibitor MOA: azole binds heme iron to prevent O2 binding',
      'Know steroidal (exemestane) vs nonsteroidal (anastrozole, letrozole) aromatase inhibitors',
      'Recognize progesterone rapid metabolism (t1/2 5-10min) necessitates synthetic progestins',
      'Differentiate pregnanes (C6 methyl for oral availability) vs 19-norandrostanes (from testosterone)',
      'Understand 19-nor (loss of C19 methyl) decreases androgenic activity',
      'Know ethinyl on androgen converts it to progestin',
      'Compare progestin androgenic activity: norgestrel/levonorgestrel (high) vs norgestimate/desogestrel (low)',
      'Recognize desogestrel → etonogestrel (active metabolite in NuvaRing)',
      'Understand mifepristone (RU-486) as progesterone antagonist/abortifacient'
    ],
    highYieldConcepts: [
      // BPH/ED/UI Med Chem
      'Alpha-1 antagonists: QUINAZOLINES with "-azosin" suffix (prazosin, terazosin, doxazosin, tamsulosin, alfuzosin, silodosin)',
      'Tamsulosin: Selective for alpha-1A (prostate) vs alpha-1B (vasculature) → less CV side effects',
      '5-Alpha-reductase isoforms: Type 1 (skin/liver), Type 2 (reproductive tissue - BPH target)',
      'Finasteride: 30x more selective for type 2. Dutasteride: 10x more potent for type 2, also inhibits type 1',
      'Both finasteride and dutasteride are STEROIDAL',
      'PDE5 inhibitors: PYRAZOLOPYRIMIDINONE class, based on GUANINE (mimic GMP), added SULFONAMIDE for water solubility',
      'Sildenafil: Only >10-fold selective for PDE5 vs PDE6 → PDE6 in retina → blue vision side effect',
      'SELECTIVITY = one drug at multiple targets. POTENCY = different drugs at single target (lower IC50 = more potent)',
      'Alprostadil (PGE1): Vasodilator, direct action, formulations: Caverject (injection), MUSE (urethral suppository)',
      'Antimuscarinics for OAB: Structurally resemble ACETYLCHOLINE (competitive antagonists)',
      'Beta-3 agonists (mirabegron): Structurally resemble EPINEPHRINE',
      'Desmopressin (DDAVP): Vasopressin analogue with oral bioavailability and longer duration',

      // Osteoporosis Med Chem
      'Bone cells: Osteogenic (stem), Osteoblasts (produce), Osteocytes (maintain), Osteoclasts (resorb)',
      'Bisphosphonates mimic INORGANIC PYROPHOSPHATE (IPP): P-C-P bond (vs P-O-P) → resistant to hydrolysis, long half-life',
      'Nitrogen-containing R2 side chain increases BPP POTENCY and TOXICITY (linked to BRONJ)',
      'Bisphosphonates: Alendronate, Risedronate, Ibandronate*, Zoledronate*, Pamidronate** (*IV available, **not for OP)',
      'Zoledronate most potent bisphosphonate',
      'PTH analogues (teriparatide, abaloparatide): NOT antiresorptive, ANABOLIC, increase osteoclastic activity, theory = build more than lose',
      'Denosumab: Monoclonal antibody binds RANKL → prevents osteoclast differentiation (antiresorptive)',
      'Romosozumab: Anti-sclerostin antibody, DUAL MOA (increases formation + decreases resorption) - UNIQUE',

      // Gonadal Hormones Med Chem
      'Sex hormone classification: Estrogens (C18, aromatic A ring, 3-phenolic OH), Progestins (C21, 3-keto-4,5-ene), Androgens (C19, oxygens at 3 and 17)',
      '3 classic estrogens: Estrone, 17β-ESTRADIOL (most potent), Estriol',
      'Aromatase (CYP19): Critical enzyme converting androgens → estrogens (requires 3 O2 + NADPH)',
      'Aromatase deficiency → failure of female sexual maturation',
      'Estradiol metabolism: Hydroxylation (2/4-positions) → catechol → COMT → O-methoxy → conjugation → excretion',
      'Estradiol ↔ Estrone (interconvertible via estradiol dehydrogenase)',
      'Estradiol poor oral BA: Rapid 17β-hydroxyl oxidation + conjugation',
      'Ethinyl estradiol: 17α-ETHINYL blocks oxidation → 15-20x more potent orally, 40% BA',
      'SAR: 17α-alkyl substituent prevents conversion to estrone (necessary for oral drugs)',
      'Mestranol: 3-O-methyl PRODRUG of ethinyl estradiol',
      '17β-Esters (valerate, cypionate): Long-acting IM prodrugs (14-28 days)',
      'Conjugated estrogens (Premarin): From pregnant MARE urine, contains equilin/equilenin (not in humans)',
      'Estrogen SAR: Removal of EITHER C3 or C17 oxygen diminishes activity; 17α-epimerization diminishes activity',
      'Stilbene derivatives (DES): Nonsteroidal estrogens, TRANS more potent, linked to neoplasia in offspring',
      'Estrogen antagonist classes: 1) Impeded (weak, rapid dissociation), 2) Triphenylethylene (strong persistent binding), 3) Aromatase inhibitors (prevent synthesis)',
      'Triphenylethylene mechanism: Strong persistent ER binding → cannot translocate to nucleus or bind chromatin',
      'Clomiphene: E-isomer (antiestrogenic) + Z-isomer (estrogenic), dosed as racemic = partial agonist',
      'Tamoxifen metabolism: CYP3A4 (demethylation), CYP2D6 → 4-hydroxytamoxifen (ACTIVE metabolite)',
      'Aromatase inhibitor MOA: N-4 azole nitrogen binds HEME IRON of CYP19 → prevents O2 binding',
      'Aromatase inhibitors: Steroidal (exemestane), Nonsteroidal triazoles (anastrozole, letrozole)',
      'Progesterone: Rapid metabolism (t1/2 5-10min), excreted as 5β-pregnanediol conjugate',
      'Synthetic progestins: PREGNANES (C6 methyl → oral availability) vs 19-NORANDROSTANES (from testosterone)',
      '19-Nor: Loss of C19 methyl → DECREASES androgenic activity',
      'ETHINYL on ANDROGEN → converts to PROGESTIN',
      'Medroxyprogesterone: 6α-methyl blocks metabolism, no androgenic activity',
      'Megestrol: 6-7 double bond reduces metabolism, used for breast/endometrial cancer',
      'Ethisterone → discovery that C19 methyl UNNECESSARY → 19-norprogesterone 8x more active',
      'Progestin androgenic activity: HIGH (norgestrel, levonorgestrel), LOW (norgestimate, desogestrel - 3rd gen), LEAST (norethindrone)',
      'Desogestrel → etonogestrel (active, in NuvaRing)',
      'Mifepristone (RU-486): Progesterone antagonist, abortifacient (600mg + misoprostol)',
      'Ulipristal (Ella): SPRM (selective progesterone receptor modulator), emergency contraception within 120H (5 days)'
    ],
    clinicalPearls: [
      'Tamsulosin\'s alpha-1A selectivity is key advantage - reduced CV effects make it preferred for elderly BPH patients',
      'Dutasteride\'s dual 5-AR inhibition is more complete but both drugs take 6+ months for full effect',
      'PDE5 inhibitor drug design principle: structure must mimic substrate (GMP) while adding drug-like properties (solubility)',
      'Selectivity vs potency distinction is fundamental to understanding drug comparisons and side effect profiles',
      'Bisphosphonate P-C-P modification is brilliant: maintains biological activity while eliminating metabolic liability',
      'PTH analogues represent opposite therapeutic approach from bisphosphonates - anabolic vs antiresorptive',
      'Romosozumab\'s dual mechanism is unique but CV contraindications significantly limit use',
      'Aromatase is the critical "switch" enzyme between androgens and estrogens - deficiency prevents sexual maturation',
      'Ethinyl estradiol\'s 17α-alkyl group is the classic solution to first-pass metabolism - used in all oral contraceptives',
      'Conjugated estrogens from horse urine represents unusual drug source with non-human estrogens',
      'Triphenylethylene mechanism shows how strong persistent receptor binding can create antagonism',
      'Clomiphene\'s racemic mixture with opposite isomer activities creates partial agonist - useful for ovulation induction',
      'Tamoxifen prodrug requiring CYP2D6: polymorphisms affect efficacy, inhibitors reduce therapeutic effect',
      'Aromatase inhibitor heme-binding mechanism is elegant enzyme inhibition at catalytic site',
      'Progesterone\'s extremely short half-life (5-10min) necessitated entire field of synthetic progestin development',
      '19-Nor modification decreasing androgenicity is key principle for developing better progestins',
      'Ethinyl converting androgens to progestins is counterintuitive but important SAR principle',
      '3rd generation progestins (norgestimate, desogestrel) have better androgenic profile but possibly higher VTE risk',
      'Mifepristone controversy demonstrates how medicinal chemistry intersects with ethics and politics'
    ],
    relatedSections: [
      'bph-pharmacology',
      'ed-pharmacology',
      'osteoporosis-pharmacology',
      'urinary-incontinence-pharmacology',
      'gonadal-hormones-pharmacology',
      'contraception-pharmacology'
    ]
  },
  flashcards: weldonFlashcards,
  quiz: weldonQuiz,
  drugCards: weldonDrugCards,
  flowchartFile: '/flowcharts/weldon.drawio'
};
